Comparison
Semaglutide vs Tirzepatide: Comparing GLP-1 Weight Loss Medications
Both are FDA-approved GLP-1 medications for weight loss and diabetes. Tirzepatide is a newer dual-agonist (GIP/GLP-1) showing greater weight loss in trials, while Semaglutide has more long-term safety data.
Semaglutide
Typical Dose: 0.25-2.4 mg
Frequency: Once weekly
Route: Subcutaneous injection
FDA Approved: Yes
Tirzepatide
Typical Dose: 2.5-15 mg
Frequency: Once weekly
Route: Subcutaneous injection
FDA Approved: Yes
Key Differences
| Aspect | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist only | Dual GIP + GLP-1 receptor agonist |
| Weight Loss | 15-17% in trials | Up to 22.5% in trials |
| Dosing | 0.25-2.4 mg weekly | 2.5-15 mg weekly |
| FDA Status | Approved since 2017 (diabetes), 2021 (weight) | Approved since 2022 (diabetes), 2023 (weight) |
| Forms | Injectable and oral (Rybelsus) | Injectable only |
When to Use Each
Semaglutide May Be Better For:
- When long-term safety data is priority
- Cardiovascular risk reduction focus
- Insurance coverage considerations
- Oral option preferred (Rybelsus)
Tirzepatide May Be Better For:
- Maximum weight loss is goal
- Superior A1C reduction needed
- GLP-1 alone insufficient
- Better GI tolerance (some patients)
Both Are Good For:
Type 2 diabetes managementChronic weight managementMetabolic syndromeCardiovascular risk reduction
Side Effects Comparison
Semaglutide
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Injection site reactions
Tirzepatide
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
The Verdict
Tirzepatide shows superior weight loss results in head-to-head trials. However, Semaglutide has more long-term safety data and an oral option. Both are effective; choice often depends on insurance, availability, and individual response.
Research Data
Semaglutide
100
Animal Studies
50
Human Studies
Tirzepatide
50
Animal Studies
30
Human Studies
Dosing Tools
Compare Different Peptides?
Use our interactive tool to compare any peptides side-by-side.
Open Compare ToolResearch Purposes Only
This comparison is for educational purposes. Consult a healthcare provider before using any peptides.